Attenuated purinergic receptor function in patients with type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Attenuated purinergic receptor function in patients with type 2 diabetes.

Attenuated purinergic receptor function in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q33556510

about

Purinergic signalling and diabetes Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists Functional sympatholysis during exercise in patients with type 2 diabetes with intact response to acetylcholine.P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected].Effect of acute inspiratory muscle exercise on blood flow of resting and exercising limbs and glucose levels in type 2 diabetes.Impaired dynamic cerebral autoregulation at rest and during isometric exercise in type 2 diabetes patients.Purinergic receptors expressed in human skeletal muscle fibres Inefficient functional sympatholysis is an overlooked cause of malperfusion in contracting skeletal muscle.Upregulation of inducible NO synthase by exogenous adenosine in vascular smooth muscle cells activated by inflammatory stimuli in experimental diabetes.Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.Linking skeletal muscle blood flow and metabolism to the limits of human performance.A physiological model for interpretation of arterial spin labeling reactive hyperemia of calf muscles.Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism.Perfusion measures for symptom severity and differential outcome of revascularization in limb ischemia: Preliminary results with arterial spin labeling reactive hyperemia.Type 2 diabetes specifically attenuates purinergic skin vasodilatation without affecting muscarinic and nicotinic skin vasodilatation and sweating.Exercise intolerance in type 2 diabetes: is there a cardiovascular contribution?The effect of purinergic P2 receptor blockade on skeletal muscle exercise hyperemia in miniature swine.Hemodynamic responses during graded and constant-load plantar flexion exercise in middle-aged men and women with type 2 diabetes.Regulatory mechanisms underlying the modulation of GIRK1/GIRK4 heteromeric channels by P2Y receptors.

P2860

Q26828574-239311AC-C6A9-40BE-85A3-192534481B6E Q28542939-542ADF3D-5473-4D75-84D9-2502BF1F07B7 Q35043742-DFEEC89D-D3E0-4061-A8AD-E53CEB500721 Q35190298-300F6FC6-3180-4CC7-B72D-4CBD2A46FF96 Q35213931-51EBDCDE-5A12-44BA-BCB0-02DE1C832477 Q35275410-D3D1122C-B526-4E5C-B256-A9133CDB8C3A Q35953973-733637C5-973C-43B0-BB43-C52F217B683F Q38044360-FAEA0610-2DC0-4F0C-8BC5-2A836FB9C7E1 Q38486377-35356FAD-2E49-4711-A111-A8E00E9ED01F Q38679517-B908FBD5-23FE-4C95-922B-ECD3874784FE Q39049804-CD29B19C-550D-42E8-9EBA-68B7A12EBF95 Q41512428-0DF8BA69-4396-4F29-BBD0-3DEC073878A7 Q43441447-3F574DF5-FF55-4D5B-A585-4A186CDCE910 Q47386369-9C7AD892-4F73-489C-850E-7B34310B6174 Q48169086-36BA0B60-BF77-463C-B344-11A61DAE12A2 Q50116162-80631BEE-C791-40D4-9581-FFE276D6AE29 Q50426563-7118427D-63F7-4AA1-B9E8-DDF79CAA355E Q50451228-9D5C8515-1A59-4994-BBEE-895995276430 Q51760756-C609BD47-F159-4946-8F6F-09AC963D3843

P2860

Attenuated purinergic receptor function in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q33556510

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Attenuated purinergic receptor function in patients with type 2 diabetes.

@ast

Attenuated purinergic receptor function in patients with type 2 diabetes.

@en

Attenuated purinergic receptor function in patients with type 2 diabetes.

@nl

type

label

Attenuated purinergic receptor function in patients with type 2 diabetes.

@ast

Attenuated purinergic receptor function in patients with type 2 diabetes.

@en

Attenuated purinergic receptor function in patients with type 2 diabetes.

@nl

prefLabel

Attenuated purinergic receptor function in patients with type 2 diabetes.

@ast

Attenuated purinergic receptor function in patients with type 2 diabetes.

@en

Attenuated purinergic receptor function in patients with type 2 diabetes.

@nl

P1433

Q33556510-E4FC6F91-25FC-4FB7-8D08-18B9635E028B

P1476

Q33556510-A7997F9C-A3DC-43B6-83CC-62E15F7A0CFA

P2093

Q33556510-228431F0-78E3-40DA-A9C3-40B47F1FC6BA

Q33556510-455C6030-350F-44E5-A657-52615400B36A

Q33556510-5021EE5B-63EA-4FF0-9BBC-39EE99688949

Q33556510-A08380EA-5EED-406F-9A20-8A22A1AA5062

P2860

Q33556510-03D3CDC1-31F6-4202-8403-12AA7B98DDE2

Q33556510-0CB26B33-B4F8-471A-832E-38ACB7D6AFF6

Q33556510-0D9055E3-6DA9-4E6D-B282-781D5BEB5651

Q33556510-105948AE-3B44-495F-9B4D-336A03233DB8

Q33556510-15505C6B-190F-46B0-9F0F-F6D2ACF41EA1

Q33556510-1ED055EA-24A8-425D-ADF7-CC3532203E0B

Q33556510-23199EEA-9AEB-4FDF-88C4-CADE22E7BD9B

Q33556510-28B835B5-FA9B-497E-B5AB-D4DA74BA18F4

Q33556510-2B2367A6-D1AE-4621-844D-94013975A8C9

Q33556510-2D269F90-3E7C-4A66-905E-FF3428DB2A19

P304

Q33556510-1D3BE637-F4EC-4459-9987-81FCB72C32F7

P31

Q33556510-158C7CB2-D0AD-43DC-8E51-6885E490DE35

P356

Q33556510-AC919C6C-82C3-4A25-9906-2F7FFA16D8AA

P407

Q33556510-55588F5E-29DD-4FCB-8531-D7B50A248F66

P433

Q33556510-E685DB46-D409-4EBD-BA92-113B3C5F71F1

P478

Q33556510-6314F192-F0D1-415A-BF0D-0D71951329FA

P50

Q33556510-95B4F5A3-F66F-4EB1-949C-4CD81C0EA86B

Q33556510-A2727749-078D-47C1-8D31-9AC02D347CAA

P577

Q33556510-ACCB564D-08AB-460F-A65D-ACFB72784FCA

P5875

Q33556510-6862C098-B133-40A1-A067-D4B39BD74405

P698

Q33556510-23B853B2-F9C1-4A15-9BB4-4B6A70009579

P921

Q33556510-D7C00585-9807-4C24-AD65-279B66625A85

P932

Q33556510-6684A6DA-8EC9-4B87-A0DA-9B30621F5841

P356

P1433

P1476

Attenuated purinergic receptor function in patients with type 2 diabetes.

@en

P2093

Bengt Saltin

http://www.w3.org/2001/XMLSchema#string

Jaya B Rosenmeier

http://www.w3.org/2001/XMLSchema#string

Laurids T Bune

http://www.w3.org/2001/XMLSchema#string

Pia Thaning

http://www.w3.org/2001/XMLSchema#string

P2860

Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle

Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise

The effect of systemic hypoxia on interstitial and blood adenosine, AMP, ADP and ATP in dog skeletal muscle

Exogenous NO administration and alpha-adrenergic vasoconstriction in human limbs.

Introduction: P2 receptors.

Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on "Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP".

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Endothelial dysfunction and hypertension in diabetes mellitus.

Vascular complications in diabetes mellitus: the role of endothelial dysfunction.

Roles of P2-purinoceptors in the cardiovascular system.

P304

182-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-1068

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Henriette Pilegaard

P577

2009-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26875868

http://www.w3.org/2001/XMLSchema#string

P698

19808895

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2797920

http://www.w3.org/2001/XMLSchema#string